Inogen reported a seventh consecutive quarter of … [Read more...]
Inogen Reports Continued Revenue Growth, Leans Into International Markets During Q3 Earnings Call
Inogen Launches Voxi 5 Stationary Oxygen Concentrator for LTC Patients
The new concentrator was designed for durability at a lower price point.
Inogen (Nasdaq: INGN) has introduced a stationary … [Read more...]
Inogen SIMEOX 200 Airway Clearance Device Receives FDA 510(k)
The manufacturer has announced a limited launch in the U.S. this year.
Inogen’s SIMEOX 200 Airway Clearance Device for … [Read more...]
Inogen CEO: Company’s ‘Great Progress’ Being Led by Strong POC Sales
The manufacturer launched the Rove 4 portable oxygen concentrator in October.
Inogen’s “great progress” in the third quarter of … [Read more...]
Inogen Launches Rove 4 Portable Oxygen Concentrator
The POC’s lightweight construction is designed to keep users ambulatory.
Inogen (Nasdaq: INGN) has launched the Rove 4 … [Read more...]
Inogen Appoints Eric Pauls as Vice President of Sales for North America
The appointment is the latest of several executive hires this year.
Inogen Inc. (Nasdaq: INGN), a provider of home … [Read more...]
Inogen Announces Q2 Financial Results, Anticipates Overall Growth in 2024
Higher demand and new customers drive growth, the manufacturer reported.
Inogen Inc. (Nasdaq: INGN) is expecting … [Read more...]
Briefly: Inogen to Announce Q2 Earnings; FDA Continues Monitoring Philips Respironics OLA+ Reports
Featuring Inogen, the U.S. Food & Drug Administration, and Philips Respironics.
Inogen to Report Q2 Earnings on Aug. 6 Inogen … [Read more...]
Inogen Appoints New General Counsel and EVP of Business Development
The new addition is a health-care industry veteran.
Inogen Inc. (Nasdaq: INGN), a provider of … [Read more...]
Inogen Earnings Call: ‘Very Modest Tailwinds’ for Home Respiratory Sales
CEO Kevin R. Smith said the company remains focused on establishing and advancing its path to profitability.
Inogen acknowledged an uptick in its home … [Read more...]